EULAR 2023 Insights
EULAR 2023 Insights: Benralizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA) - Results From a European Multicenter Study
By
EULAR 2023 Insights
FEATURING
Alessandra Bettiol
By
EULAR 2023 Insights
FEATURING
Alessandra Bettiol
Login to view comments.
Click here to Login
